−0.01EUR
−1.08 MEUR
1.47 MEUR
About LIPIGON PHARMACEUTICALS AB
Sector
CEO
Stefan Kristoffer Nilsson
Headquarters
Umeå
Website
Founded
2010
ISIN
SE0015382072
FIGI
BBG00ZHCXYX0
Lipigon Pharmaceuticals AB engages in the development of drugs for diseases caused by disruptions in the body's handling of lipids. It focuses on small molecules, gene therapy, and antisense for patients with lipid disorders and other cardiometabolic risk factors. The company was founded by Stefan Kristoffer Nilsson on April 6, 2010 and is headquartered in Umeå, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 9RP is 0.03 EUR — it hasn't changed in the past 24 hours. Watch LIPIGON PHARMACEUTICALS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange LIPIGON PHARMACEUTICALS AB stocks are traded under the ticker 9RP.
9RP stock has fallen by 3.70% compared to the previous week, the month change is a 3.70% fall, over the last year LIPIGON PHARMACEUTICALS AB has showed a 27.41% decrease.
We've gathered analysts' opinions on LIPIGON PHARMACEUTICALS AB future price: according to them, 9RP price has a max estimate of 0.22 EUR and a min estimate of 0.22 EUR. Watch 9RP chart and read a more detailed LIPIGON PHARMACEUTICALS AB stock forecast: see what analysts think of LIPIGON PHARMACEUTICALS AB and suggest that you do with its stocks.
9RP stock is 0% volatile and has beta coefficient of −0.20. Track LIPIGON PHARMACEUTICALS AB stock price on the chart and check out the list of the most volatile stocks — is LIPIGON PHARMACEUTICALS AB there?
Today LIPIGON PHARMACEUTICALS AB has the market capitalization of 2.88 M, it has decreased by 11.52% over the last week.
Yes, you can track LIPIGON PHARMACEUTICALS AB financials in yearly and quarterly reports right on TradingView.
9RP net income for the last quarter is −641.85 K EUR, while the quarter before that showed −675.68 K EUR of net income which accounts for 5.01% change. Track more LIPIGON PHARMACEUTICALS AB financial stats to get the full picture.
No, 9RP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LIPIGON PHARMACEUTICALS AB EBITDA is −1.16 M EUR, and current EBITDA margin is −76.51%. See more stats in LIPIGON PHARMACEUTICALS AB financial statements.
Like other stocks, 9RP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LIPIGON PHARMACEUTICALS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LIPIGON PHARMACEUTICALS AB technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LIPIGON PHARMACEUTICALS AB stock shows the sell signal. See more of LIPIGON PHARMACEUTICALS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.